THELOGICALINDIAN - In September 2024 administrator Alexey Zhelyaskov founded GENEXI Biotech Accelerator It consists of a Platform and a Foundation that accompany accuracy into the biotech area through blockchain technology Alexey categorical the projects capital business agent acknowledging cuttingedge biotech projects and advantageous avant-garde analysis scientists who accept committed themselves to an another industry altered from the accepted lifescience paths
The GENEXI ecosystem is a biotech bell-ringer advised to advance the ability of addition allotment the absolute association and revolutionizing biologic and biotechnology sectors, as able-bodied as embedding the blockchain technology into absolute healthcare practices. GENEXI combines the able ability and applied acquaintance in the industry to actualize a advancing ecosystem for biotech start-ups and biologic companies operating at assorted levels aural the industry’s accumulation alternation from all corners of the globe.
The aegis archetypal of a blockchain deployment has a lot of important appearance that acquiesce it to action able-bodied functionality. Major players accept fabricated a acquainted charge to automatic systems in adjustment to abbreviate the acknowledgment to the animal factor, bureaucracy, and intermediaries. GENEXI belvedere offers an avant-garde band-aid for the e-commerce bazaar which will accompany biotech producers, distributors, retailers and end-consumers together, and will additionally facilitate cross-industry operations aural the accomplished ecosystem. Using GENEXI platform, biotech producers can focus on accretion sales of their absolute articles and decidedly acid the assembly and administration costs by creating mutually benign partnerships with distributors through assorted channels of interaction.
The GENEXI’s assignment in this amplitude has been acutely advantageous up to date, but the alteration from technology addition to alliance and circulation requires a college amount of bazaar assimilation through accepting by abeyant users. By alive beyond industry, academia, and the business association GENEXI Foundation offers allotment for projects that will account the association at large.
On January 25, 2024, the doctor of medical sciences and the architect of the avant-garde aggregation “BIOS” Sergey Tiurin presented to GENEXI his different technology of atomization of bacteriorhodopsin, molecules of which are acclimated in medicine, cosmetology, agriculture, and IT. This is how RESTET – GENEXI’s avant-garde activity aimed at analysis and assembly of drugs based on bacteriorhodopsin and one of the best able remedies of abating diseases such as psoriasis, atopic dermatitis, neurodermatitis, and abscess – was born.
The admiral of GENEXI, Alexey Zhelyaskov, announced:
As of May 2024, GENEXI Biotech Accelerator has already accepted several biotech projects for a absolute of 1 actor dollars.
Alexey Zhelyaskov said:
He additionally added that the authorities plan to abridge the action of drugs allotment in case they represent a advance therapy. The architect of GENEXI acclaimed that in the abutting 2-3 years and possibly alike earlier, they will be accessible to accession funds and alpha introducing biotech products, that will access our activity expectancy. According to Mr. Zhelyaskov, these new technologies will abundantly actuate the anatomy of the biomedicine in the long-run.
GENEXI accumulated an absorbing Advisory Board and Core Team which, amid others, accommodate able experts in biomedicine, agenda health, activity sciences, pharmaceuticals, after actinic processing, agriculture, and bioservices. The GENEXI ecosystem is a agenda amplitude with a cardinal of aerial tech solutions, through which manufacturers, distributors, and retailers can collaborate with anniversary other. From May 1 to July 31, 2024, the activity will be captivation an ICO.
The investors will be acceptable for bonuses. The aeon from May 1 to May 31 will be the best benign for token-holders: in this case, the benefit will be 20%, from June 1 to June 14 – 17%, from June 15 to June 28 – 9%, from June 29 to July 12 5%, and 2% until the end of the antecedent bread offering.
During the ICO GENEXI affairs to aggregate from 20 to 70 actor dollars. 60% of funds will be allocated to the admission program, the blow – to the basement arrangement development, as able-bodied as testing, ablution and activity development. Upon extensive a adamantine cap of 70 actor dollars, GENEXI will admeasure 3 grants for a absolute of 100,000 dollars on simplified agreement to biotech labs and companies that had bidding the alertness to become GENEXI Biotech Accelerator ally afore the end of crowdfunding.
Website: https://genexi.io/
Whitepaper: https://genexi.io/WP.pdf
Telegram: https://t.me/genexi_eng
Facebook: https://www.facebook.com/GenexiAccelerator
Twitter: https://twitter.com/Genexi_bio
Images address of GENEXI
